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Summary An in vivo study of tissue distribution kinetics and photodynamic therapy (PDT) using 5-
aminolaevulinic acid (ALA), chlorin e6 (Chl) and Photofrin (PII) was performed to evaluate the selectivity of
porphyrin accumulation and tissue damage effects in a tumour model compared with normal tissue. C26 colon
carcinoma of mice transplanted to the foot was used as a model for selectivity assessment. Fluorescence
measurements of porphyrin accumulation in the foot bearing the tumour and in the normal foot were
performed by the laser-induced fluorescence (LIF) system. A new high-intensity pulsed light delivery system
(HIPLS) was used for simultaneous irradiation of both feet by light in the range of 600-800 nm, with light
doses from 120 to 300 J cm-2 (0.6 J cm-2 per pulse, 1 Hz). Photoirradiation was carried out 1 h after injection
ofALA, 3 h after injection of Chl and 24 h after injection ofPII. A ratio ofporphyrin accumulation in tumour
vs normal tissue was used as an index of accumulation selectivity for each agent. PDT selectivity was
determined from the regression analysis of normal and tumour tissue responses to PDT as a function of the
applied light dose. A normal tissue damage index was defined at various values (50, 80 and 100%) of anti-
tumour effect. The results of the LIF measurements revealed different patterns of fluorescence intensity in
tumour and normal tissues for ALA-induced protoporphyrin IX (ALA-PpIX), Chl and PIT. The results ofPDT
demonstrated the differences in both anti-tumour efficiency and normal tissue damage for the agents used. The
selectivity of porphyrin accumulation in the tumour at the time of photoirradiation, as obtained by the LIF
measurements, was in the order ALA-PpIX > Chl >PII. PDT selectivity at an equal value of anti-tumour effect
was in the order Chl >ALA-PpIX > Pll. Histological examination revealed certain differences in structural
changes of normal skin after PDT with the agents tested. The results of PDT selectivity assessment with respect
to differences in mechanisms of action for ALA, Chl and PII are discussed.
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Photodynamic therapy (PDT) with Photofrin is currently
used for the treatment of cancer in many clinical studies. In
order to improve the effectiveness of this anti-cancer modality
a number of new photosensitisers have been developed and
suggested as promising agents for PDT (Gomer, 1991). Some
of the most desirable properties for new agents are (1)
selective retention by tumours; (2) maximal anti-tumour
efficiency with minimal damage to the surrounding normal
tissue; (3) rapid body clearance to reduce toxicity. Because
comparative studies of different photosensitisers' selectivity
are rare, such studies could improve our knowledge and
understanding concerning mechanisms involved in tissue
response to PDT.
Three different agents, chlorin e6 (Chl), 5-aminolaevulinic
acid (ALA) and the standard photosensitiser Photofrin (PII)
were investigated in this study.
Chlorins are known as photosensitisers with strong
absorption in the red spectrum (around 660 nm), and good
photophysical properties (Spikes, 1990; 1993). Chl has been
shown to be an effective in vivo photosensitiser, with low
toxicity and preferential tumour localisation (Kostenich et al.,
1991, 1993, 1994). The enhanced PDT efficacy and reduced
duration of cutaneous photosensitivity for mono-L-aspartyl
chlorin e6 (NPe6), a derivative ofChl, as compared withPll has
been demonstrated (Gomer and Ferrario, 1990). Stage I clinical
trials with some chlorins are currently in progress at several
medical centres.
ALA is a precursor of endogenous porphyrins, and it has
the ability to stimulate the overproduction of endogenous
protophyrin IX (PpIX) in tumour cells (Malik and Lugaci,
1987; Kennedy et al., 1990). PDT with topical ALA
application has been used extensively for the selective
eradication of human malignant skin tumours (Kennedy and
Pottier, 1992; Svanberg et al., 1994; Cairnduff et al., 1994;
Orenstein et al., 1996). Unfortunately, there are relatively few
preclinical studies on the ALA potential for PDT after
systemic administration (Peng et al., 1992; Bedwell et al.,
1992; Regula et al., 1994). The advantages of ALA-PDT are
(1) low systemic toxicity (Kennedy and Pottier, 1992); (2)
endogenous PpIX synthesis and compartmental targeting
(mitochondria) for PDT damage (Malik and Lugaci, 1987;
Peng et al., 1992; (3) rapid clearance of ALA-induced
porphyrins from the body (Bedwell et al., 1992).
The differences in biological mechanisms of action
(exogenous vs endogenous) and in photophysical properties
of ALA-PpIX, Chl and PII make the comparison of these
agents interesting. A reliable test model with a tumour
transplanted into the footpad (Evensen and Moan, 1987;
Zhuravkin et al., 1992) was chosen in the present
investigation. To study the accumulation selectivity of the
agents, laser-induced fluorescence (LIF) measurements were
performed. The LIF method has been applied in vivo to
analyse the pharmacokinetics of various photosensitisers
(Kennedy et al., 1992; Frisoli et al., 1993; Malik et al.,
1995). This method is non-invasive and rapid, and therefore
optimal for such experiments.
The aim of this study was to compare the tissue
accumulation and therapeutic selectivities of ALA-PpIX,
Chl and PII in a C26 colon carcinoma model. The bases
for comparison were LIF measurement data and the
assessment of tumour and normal tissue responses to PDT.
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Materials and methods
Animal and tumour model
For experimental studies, 7 to 9-week-old female BALB/c
mice were used. The C26 colon carcinoma cell line was
maintained at 37°C in RPMI-1640 medium containing 10%
fetal calf serum and was subcultured twice a week. Tumours
were obtained by subcutaneous injection of 5 x 105 cells into
the hind footpad of the mice. The tumour thickness was 4-
6 mm 12-14 days after the implantation. The mice received
a special diet, which excluded chlorophyll compounds.
Chemicals
5-Aminolaevulinic acid (ALA) was purchased from Sigma (St
Louis, MO, USA). Photofrin II (Pll) was purchased from
QLT Phototherapeutics (Vancouver, BC, Canada). Chlorin e6
(Chl) was obtained from the Laboratory of Photochemistry,
Byelorussian Academy of Sciences (Minsk). The agents were
dissolved in a saline solution (ALA), or phosphate buffer
solution at a pH of 8.0 (Chl and PII) just before application,
and were administered intraperitoneally at the following
doses: ALA, 200 mg kg-'; Chl, 5 mg kg-'; PII, 10 mg kg-'.
The doses of the agents were chosen from our PDT
experience and preliminary experiments, which showed that
a similar range of the light doses was thereby possible for all
three agents.
Laser-inducedfluorescence analysis
A 502 nm line of argon-ion laser (Coherent, Palo Alto, CA,
USA model Innova 200) was used for fluorescence
excitation in tissues. The laser light was passed through
an'interference filter and transferred to the sample via one
of the legs of a bifurcated fibre bundle (Oriel, Stratford,
CT, USA model 77533). The common end tip of this
bundle was fixed at a distance of 8 mm from the object to
form a light spot of about 5 mm in diameter. The beam
power was measured with a laser power meter (Ophir,
Israel, model PD2-A) and was 15 mW (power density 54
mW cm-2). The end tip of the second leg of the bundle was
placed in front of the entrance slit of a digital fluorimeter
(Perkin-Elmer, Norwalk, CT, USA model LS-50B) with a
longpass filter (Schott, Germany, type OG 530). The filter
was used for transmission of the fluorescence signal and
also for blocking the laser light excitation. Fluorescence
emission spectra were recorded from 570 to 740 nm.
Background signals were subtracted from the spectra, and
fluorescence intensities at a maximum for each agent (635
nm for ALA-induced PpIX, 667 nm for Chl and 630 nm for
PII) were used as the data for kinetic curves. The time of a
fluorescence spectrum recording was 10 s and an average of
several recordings was used for each kinetic data point. The
tumour-normal tissue ratio of agent accumulation was
calculated as (I,-In)/IL, where I, and In are the fluorescence
intensities in the foot with the tumour and the normal foot
respectively.
Photoirradiation procedure
A new high-intensity pulsed light delivery system for PDT,
the Photodyne (Energy Systems, ESC, Haifa, Israel), was
used as a light source. The parameters of irradiation were
controlled by an IBM 486 computer with original software
and were as follows: the wavelength range, 600-800 nm; the
length of pulses, 2 ms; delay between pulses, 1 s; light energy
density per pulse, 0.6 J cm-2. Maximum temperature in the
tumour tissue during photoirradiation at this regimen
(measured by thermocouple) was 38-39°C.
The mice were anaesthetised with Nembutal (60 mg kg-')
5- 10 min before photoirradiation and were then placed in a
special plastic tube. The normal foot and the foot with the
implanted tumour were each passed through a hole, affixed
just outside the tube and irradiated simultaneously.
Histological study
Twenty-four hours after photoirradiation, three animals from
each group were killed, and tissue samples from the foot with
the tumour and from the normal foot were excised and fixed
in a 10% formalin solution. Histological sections were
prepared, cut and stained with haematoxylin and eosin.
Tumour response assessment
Three orthogonal diameters (DI, D2 and D3) of the tumour
were measured with callipers three times a week, and the
tumour volume was calculated by the formula
V= r/6(D, xD2x D3).
Tumour growth was described by the exponential equation
V,= Voek" (in its logarithmic form lnV,=lnVV +kt), where V.
and V, are the tumour volumes before and after the
treatment, respectively, t is the time interval after the
treatment and k is the constant of tumour growth rate,
which was determined by the least-square method.
The anti-tumour effect of the treatment was determined as
the inhibition of tumour growth rate when compared with
the untreated control. Tumour growth inhibition ratio
(TGIR) was calculated as TGIR=[(kc-ke)/k] x 100%,
where kc and ke are the constants of tumour growth in the
control and the experimental groups of animals respectively.
The dose of photoirradiation which caused 50% TGIR
(ED50) was calculated by the least-square method after fitting
the dose-response curve.
Normal tissue damage assessment
The thickness of the normal foot was measured three times a
week and the value ofthe oedema ratio was calculated as (D,/
D)- 1, where Do and D, are the size of the foot before and
after the treatment. The normal tissue damage index (DI) was
determined as an area under the oedema ratio curve.
A comparative study was performed after determination of
the normal foot damage index and the tumour growth
inhibition as a function of the light dose applied for each
agent. The data of normal tissue response were plotted vs the
anti-tumour effect, and the values of DI at the defined values
(50%, 80% and 100%) of anti-tumour effect (TGIR) were
calculated for each agent by the least-square method.
Results
In order to evaluate tissue distribution and PDT selectivity of
ALA-induced PpIX, Chl and PII, an objective model was
defined and the following parameters were determined: (1)
tumour-normal tissue accumulation ratio; (2) dose-effect
relationship of PDT damage to tumour and normal tissues;
(3) normal tissue response per defined values of anti-tumour
effect for each photosensitiser as an index of PDT selectivity.
In vivo fluorescence monitoring
In vivo fluorescence spectra obtained by the LIF method after
injection of ALA, PII and Chl are shown in Figure 1.
Autofluorescence was not detectable in either the control or
the experimental animals before injection of the agents. The
fluorescence spectrum observed after ALA administration
had two PpIX peaks, the dominant peak at 635 and the
minor peak at 704 nm. The in vivo fluorescence spectrum of
Chl had one intensive peak at 667 nm, and PII spectra had
two peaks, at 630 and 692 nm.
The kinetics of ALA-induced PpIX, Chl and PII
accumulation in normal and tumour tissues are shown in
Figure 2A-C. A maximal level of fluorescence intensity in
the foot with the tumour was found 1 h after ALA injection,
while in the normal foot, fluorescence reached a maximum
value at 3 h (Figure 2A). After reaching maximal levels in
both the normal tissue and the tumour, the fluorescencedecreased gradually at a similar rate for both feet and was
minimal 24 h after ALA administration. A maximal
tumour-normal tissue ratio of the fluorescence signal (2.3)
was revealed 1 h after ALA injection (Table I).
A different pattern of accumulation was observed after
injection of Chl (Figure 2b). A maximum Chl fluorescence
was detected in both feet 1.5 h after the injection and then it
decreased rapidly. The fluorescence intensity was higher in
the tumour than in the normal tissue over 24 h, with the ratio
about 0.7.
Maximum fluorescence intensity of PII in the tissues was
observed 6 h after the injection (Figure 2c). Fluorescence
signals from both feet were equal at this time. Slower
elimination of the agent from the tumour than from the
normal tissue resulted in an increase in the fluorescence
intensity ratio between both feet from 0.4 to 0.7 at 24-72 h
after injection.
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damage in the skin and in the tumour. The data of
morphological changes observed in both feet are summarised
in Table II. The results show that different degrees of
epidermal damage, stasis and oedema in the dermis,
prominence of the inflammatory infiltrates and extravasa-
tion of erythrocytes were evaluated for all three agents.
Tumour necrosis was observed 24 h after PDT with all three
agents (Figure 3). The occurrence of the inflammatory
infiltrate of granulocytes in the tumour tissue was more
pronounced for ALA-PDT (Figure 3b, b'). Extensive
extravasation of erythrocytes with minimal infiltration of
granulocytes was seen after PDT with both Chl or PII
(Figure 3c-d). It was also found that PII-PDT caused
focal damage to vascular walls (vacuolar changes) as well as
focal thrombus formation (Figure 3d').
Figure 4a-c demonstrates the characteristic morphologi-
cal features observed in the skin of the normal foot after
Morphological study of tissue damage effects after PDT
For PDT, both the normal foot and the foot with the
transplanted C26 colon carcinoma were irradiated by pulsed
light from a HIPLS 1 h after injection of ALA, 3 h after
injection of Chl and 24 h after injection of PII. A typical
sequence of effects observed on both feet after PDT with all
three agents was oedema followed by necrosis and crust
formation. The expression of damage after the treatment with
each agent was directly dependent on the light dose applied.
Oedema was significantly more pronounced in the normal
foot than in the foot with the tumour. Tissue necrosis,
ulceration and crust formation was typically observed 2-5
days after the treatment.
Histological examination of tissue samples from the foot
with the tumour and the normal foot, performed 24 h after
PDT with ALA-induced PpIX, Chl and PII, revealed
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Figure 1 In vivo fluorescence spectra of chlorin e6 (Chl) .......
ALA-induced protoporphyrin IX (PpIX), , and Photo-
frin II (PII), - - - -, in mice with subcutaneously located C26
tumour.
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Figure 2 Kinetics of in vivo fluorescence in the foot with C26
colon carcinoma 0 and in the normal foot M of mice after
injection of 200 mg kg'- ALA (a), 5 mg kg- 1 Chl, (b) and 10 mg
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Table I Agent characteristics in accumulation selectivity, PDT efficacy (ED50) and normal tissue damage at different values of anti-tumour
effect (TGIR)
Normal tissue damage index
Tumour/normal tissue ED50
Agent accumulation ratio (J cm-2) TGIR 50% TGIR 80% TGIR 100%
ALA 2.1 +0.6 199+5 0.86+0.15 1.10+0.2 1.25±0.15
Chl 0.7+0.1 136+4 0.05+0.01 0.12+0.05 0.23+0.1
PIl 0.4+0.1 153+7 0.2+0.1 1.43+0.15 3.3+0.2
All differences between groups are statistically significant.
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Table II Morphological changes in the skin and C26 tumour after PDT
Acute inflammatory Extravasation of
Agent Epidermis Dermal oedema infiltrate erythrocytes Blood vessels
ALA Necrosis with inflammatory Minimal Severe Minimal Stasis, undamaged wall
infiltration by granulocytes
Chl Mostly normal Moderate Minimal Severe Severe stasis, undamaged wall
PII Vacuolar changes Severe Minimal Severe Severe stasis, damaged wall
Figure 3 Histology of foot with C26 tumour samples in untreated control (a) and, after PDT with ALA (b,b'), damaged epidermis
and pronounced infiltration by granulocytes in the skin and underlying tumour; Chl (c), moderate oedema, tumour necrosis with red
blood cell extravasation; PII (d), severe dermal oedema with blister formation, tumour necrosis with red blood cell extravasation,
(d'), blood vessel with damaged wall and small thrombus formation. Haematoxylin and eosin, a,b,b',c,d x 625; d' x 825.
treatment with the agents tested. Extensive damage to the
epidermis with coagulative necrosis, blurred dermoepidermal
junctions and a severe reaction of granulocytes were
characteristic of ALA-PDT (Figure 4a). In contrast,
undamaged epidermis was noted after Chl-PDT (Figure
4b). Moderate damage to epidermis, severe dermal oedema
and blood stasis was pointed for PII-PDT (Figure 4c).
Anti-tumour effect assessment after PDT
Figure 5 shows the tumour growth curves after PDT with
ALA-induced PpIX (a), Chl (b) and Pll (c) at doses of
photoirradiation in the range 120-300 J cm-2. Photo-
irradiation alone, or each of the agents alone did not affect
tumour growth, compared with the untreated control. PDT
using the agents resulted in tumour necrosis and delay of
tumour growth rate. Tumour growth inhibition increased
with an increase in the light dose. Figure 6 demonstrates
the logarithmic character of the dose-response curves,
which was observed for all three agents. Comparing PDT
anti-tumour efficiency of each agent according to the
regimens used (agent dose and time between injection and
photoirradiation), Chl showed the highest effect (ED50 for
photoirradiation 136 J cm-2), while ALA-PpIX showed the
lowest (ED50 for photoirradiation 199 J cm-2) Table I.
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Figure 5 Tumour growth curves in control (ten mice) and after
PDT (eight mice in each group) with different light doses. (a)
ALA (200 mg kg-1) was injected 1 h before photoirradiation. (b)
Chl (5mg kg-') was injected 3 h before photoirradiation. (c) PII
(10 mg kg-1) was injected 24 h before photoirradiation. Error
bars = s.e. *, control; *, 120 J cm-2; A, 180 J cm-2; V, 240 J
cm-2; O, 300 J cm-2.
Figure 4 Histology of normal foot samples after PDT with ALA
(a), damaged epidermis and pronounced infiltration by granulo-
cytes; Chl (b), undamaged epidermis and moderate oedema; PII
(c), damaged epidermis, severe dermal oedema with blister
formation. Haematoxylin and eosin, x 400.
Normal tissue damage assessment after PDT
Oedema of the normal foot appeared immediately after
photodynamic treatment, reached the maximal level 24 h
after the photoirradiation procedure and decreased slowly to
pretreatment level during the next 5-7 days for ALA-PDT,
4-5 days for Chl-PDT and 4-13 days for PII-PDT (Figure
7a-c). The amount of oedema, and the damage index (DI)
for the normal foot were directly dependent on the light dose
applied (Figure 8). The results indicate different patterns of
dose-effect curves of DI for the agents. A minimal effect on
normal tissues was noted for Chl. PDT with PII caused about
the same normal tissue damage as Chl at low light doses
(120-180 J cm-2); however, significant oedema of the normal
foot was observed when higher light doses were applied. The
normal foot response to ALA-PDT at low light doses was
higher than with Chl or PII. With increase of the light dose,
however, the response of normal tissues increased more
slowly after ALA-PDT than after PII-PDT. As a result, the
values of normal foot DI at light doses of 240 and 300 J
cm-2 were 2 and 3.5 times lower with ALA than with PII.
Based on the data of tumour and normal tissue damage after
PDT, the extent of normal tissue response at different values
of TGIR were calculated for each agent (Table I). The results
show that the highest PDT selectivity was observed for Chl.
The normal foot damage index after ALA-PDT was higher
than after PII-PDT at TGIR 50%; however, at TGIR 80%
or TGIR 100%, the value of this parameter was 1.3 and 2.6
times lower with ALA than with PIT.
Discussion
The experimental model and approach used in this study
allowed comparison of the tissue accumulation and
therapeutic selectivities of agents with different photophysi-
cal and photobiological properties. For this purpose three
tests (fluorescence detection, therapeutic and histopathologi-
cal) have been performed.
LIF measurements were performed to determine an
optimal time between injection and photoirradiation and
revealed different kinetics of tissue accumulation for the
agents tested (Figure 2). In the model used the LIF signals
collected from the foot with the tumour were composite
signals from the skin and underlying tumour, whereas in the
normal foot the signal was obtained from the skin and
underlying muscles. Although the fluorescence signal from
the tumour was attenuated by the skin, the kinetic patterns
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Figure 8 Normal tissue damage index as a function of light dose
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during the first 24 h (Figure 2b). The selectivity of porphyrin
accumulation in the tumour at the time of photoirradiation
obtained by the LIF measurements was in the order
ALA>Chl> PII (Table I).
Results of the PDT study using photoirradiation by
HIPLS revealed that both the anti-tumour effect and the
normal tissue damage index were enhanced with increasing
light doses for all agents (Figures 6 and 8). In order to
correctly compare PDT selectivity, an assessment of the
normal tissue damage index per equal anti-tumour effect
(TGIR) was performed. This evaluation is based on the
regression analysis of normal and tumour tissue responses to
PDT as a function of the applied light dose. Such an
assessment can be performed at the optimal regimen for each
PDT agent and disregards the differences in administered
doses (tissue concentrations) and differences in their
photophysical properties.
The results of the present study showed that with the
treatment regimens used Chl was more effective than PII and
ALA-induced PpIX for inhibition of tumour growth (Figure
6), and caused minimal damage (expression of oedema value)
5 6 7 to normal tissue (Table I). Therapeutic selectivity of the
agents at minimal values of anti-tumour effect (TGIR 50%)
was in the order Chl >PII>ALA, but the order
Chl>ALA>PII was obtained when the anti-tumour effect
was more significant (TGIR 80% and TGIR 100%). This was
the result of more prolonged normal foot oedema after PII-
PDT than after Chl-PDT or ALA-PDT, when high doses of
photoirradiation were applied (Figure 7). These observations
can reflect the peculiarities in biological properties of the
'
12 4 agents (pharmacokinetics and tissue distribution, character of
8 10 12 14 tissue damage effects, etc).
,atment (days) The difference in PDT selectivity observed between Chl
and PIT correlates well with the LIF test, which showed a mpression after PDT with higher tumour-normal tissue accumulation ratio at the
nrg kg'-) was injected 3 h moment of treatment for Chl than for PII. It has been
ng kg-l) was injected 24 h shown that the mechanism of anti-tumour effect after PDT
Ls in each group were used. with chlorins (Chl or NPe6) and PII is similar and based on
*, 240 J cm 2; A, 180 J damage to the microvasculature and blood circulation
disturbances leading to tumour necrosis (Kostenich et al.,
1991; Nelson et al., 1988). Nevertheless, different ultra-
structural changes in the subendothelial zone, and fragmenta-
:n changes in the tissues. tion (NPe6) vs coalescence (PII) of collagen fibres has been
,ed PpIX production was found (Nelson et al., 1988). It has also been shown that
rn in tumour and slower damage to the endothelial cells (with a subsequent release of
gure 2a). As a result, the the vasoactive compounds provoking vessel constriction) and
io ofporphyrin accumula- macromolecular leakage from venules were observed after
Dn of ALA, followed by a PDT with PII (Fingar et al., 1990, 1992). In contrast, no
itrast, Pll was retained by vessel constriction and minimal macromolecular leakage from
f tumour accumulation venules was noted after PDT with NPe6 (McMahon et al.,
ched maximal values at 1994). We suggest that the same differences in PDT effects
n of Chl, rapid accumula- can occur between Chl and PII. Although blood circulation
in the normal tissues was disturbances and haemostasis, resulting in tissue anoxia and
e signal in the foot with nutritional deficiency, are probably the dominant factors
r than in the normal foot responsible for tumour necrosis after PDT with chlorins and
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Pll, other mechanisms such as direct cytotoxic effects have
also been shown for Chl and NPe6 and may be involved in
tumour response to PDT (Kostenich et al., 1991; McMahon
et al., 1994). Histological examination carried out in the
present study revealed that blood stasis, oedema and
haemorrhages occurred in normal and tumour tissues after
PDT with both agents. However, certain differences have
been found: PH-PDT, as compared with Chl-PDT, caused
more pronounced damage to epidermis, induced more severe
oedema and subepidermal blister formation, caused damage
to the blood vessel walls and induced thrombi formation
(Figures 3 and 4).
ALA-PDT has a different systemic mechanism than either
Chl or PH. The endogenous route of ALA-induced PpIX
production presupposes that mitochondrial damage leads to
direct cell killing (Malik and Lugaci, 1987). The LIF test data
showed the highest tumour-normal accumulation ratio for
ALA-induced PpIX in our tumour model. Enhanced PDT
selectivity was expected after ALA administration, but in fact
was not found at low light doses. The results demonstrated
that oedema of the normal foot after ALA-PDT with light
doses of 120-180 J cm-2 was more pronounced than after
Chl-PDT or PH-PDT, but when the light doses increased,
normal tissue damage was less than for PII-PDT (Figure 8,
Table I). At the high light doses the selectivity was higher for
ALA-PDT than for PII-PDT.
We suggest that these results can be explained by the
histological examinations, which showed that the epidermis
was extensively damaged after ALA-PDT, as compared with
Chl and PH (Figures 3 and 4). This is consistent with
previous findings revealing increased PpIX fluorescence in the
epidermis and high skin photosensitivity after ALA admin-
istration (Peng et al., 1992; Divaris et al, 1990). During
photoirradiation the relatively thin epidermis layer receives
the highest light dose in addition to the preferential
production of PpIX occurring in this layer. Therefore, even
at low light doses epidermal necrosis and subsequent acute
inflammatory reaction can result in pronounced oedema.
In the tumour, some of the morphological changes after
ALA-PDT were quite different from those observed after
PDT with Chl or PH and could be attributed to direct
parenchymal tumour cell kill with slight damage to tumour
vasculature. Moderate oedema with significant granulocyte
infiltration observed after treatment is the indirect proof of
preserved blood circulation in the tissue. Nevertheless,
vascular damage during ALA-PDT cannot be excluded at
certain light doses, because systemic administration of ALA
can induce enhanced PpIX synthesis in the endothelial cells.
This fact is based on the observation of blood stasis after
photoirradiation with doses of 240 and 300 J cm-'.
In conclusion, it is suggested that selectivity of PDT for
different photosensitisers may be determined by biological
mechanisms of action such as agent-specific interstitial
distribution (binding sites) and the characteristics of tissue
damage effects. The results of the present study indicate that
integrated information obtained from a LIF study, a PDT
selectivity test and a histopathology examination is useful in
the evaluation of different agents. The experimental model
and approach described can be used to assess new potential
photosensitisers.
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